US8592581, 5

ID: ALA3655766

Chembl Id: CHEMBL3655766

PubChem CID: 57463052

Max Phase: Preclinical

Molecular Formula: C20H27N7O

Molecular Weight: 381.48

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](Nc1nc(NCc2cccnc2)c2ncn(CC3CC3)c2n1)[C@@H](C)O

Standard InChI:  InChI=1S/C20H27N7O/c1-3-16(13(2)28)24-20-25-18(22-10-15-5-4-8-21-9-15)17-19(26-20)27(12-23-17)11-14-6-7-14/h4-5,8-9,12-14,16,28H,3,6-7,10-11H2,1-2H3,(H2,22,24,25,26)/t13-,16+/m1/s1

Standard InChI Key:  BZUYVWAZFWOBLI-CJNGLKHVSA-N

Associated Targets(Human)

CDK9 Tchem Cyclin-dependent kinase 9 (2495 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem Cyclin-dependent kinase 2 (9050 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 381.48Molecular Weight (Monoisotopic): 381.2277AlogP: 2.81#Rotatable Bonds: 9
Polar Surface Area: 100.78Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.36CX LogP: 2.10CX LogD: 2.10
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -0.97

References

1.  (2013)  Trisubstituted purine derivatives, 

Source

Source(1):